Posts in tag

PBAC


Government extends Safety Net early supply rule for 60-day scripts to reduce medicines wastage  Changes to the Pharmaceutical Benefits Scheme (PBS) Safety Net early supply rule come into effect today …

Eli Lilly’s Mounjaro would need “substantial price reduction”, says PBAC Mounjaro, the type-2 diabetes medication that the New York Times recently predicted “’could overshadow Ozempic” has been refused funding via …

Community pharmacists are being urged to “keep the pressure on the government” to limit the adverse impacts of 60-day dispensing  Government officials need to restart negotiations with community pharmacy leaders …

Trust between the government and community pharmacy is broken, Professor Trent Twomey, Pharmacy Guild of Australia national president believes  Labor’s decision to push ahead with its plans for 60-day dispensing …

The controversial decision to restrict prescribing fluticasone propionate for young children has been reversed in a move welcomed by the Guild But families and pharmacists have been left without clear …

Increasing dispensing limits from 30 to 60 days’ supply of medication through the Pharmaceutical Benefits Scheme (PBS) is back on the agenda  Ahead of the federal Budget in May, Mark …

PBAC gives OK to imports of drought-stricken Ozempic and Trulicity but won’t allow supplier to charge higher price  Emergency imported supplies of overseas supplies of shortage-plagued Ozempic (semaglutide) and Trulicity …

Decrease in esomeprazole and increase in pantoprazole scripts likely due to restriction changes, says PBAC, though full picture obscured by lack of OTC and private data Restriction changes established in …

PBAC recommends listing of adalimumab biosimilar The PBAC has recommended the Authority Required listing of adalimumab (Yuflyma) in the form of 40 mg in 0.4 mL pre-filled syringe and pre-filled …

Patients have been shifting to lower dose PPIs following PBS listing changes, review reveals, but more investigation is needed The Drug Utilisation Sub-Committee (DUSC) of the PBAC has found positive …

Pharmacy has a prominent role in the supply and provision of biosimilar medicines, and the profession has been slow to come to terms with this. Is the situation now changing? …

Mixed messages from the Department of Health over two-month prescriptions, as new documents say pharmacist mark-ups will impact consumer and taxpayer savings New Department of Health documents reveal that two-month …